Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.